Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial

Authors:

Abstract
Key Points: The use of low-molecular-weight heparin did not improve live-birth rates in nonthrombophilic women with consecutive recurrent miscarriage. Prophylactic doses of low-molecular-weight heparin should no longer be prescribed in this clinical setting.

This publication has 35 references indexed in Scilit: